Replay, a genomics toolkit startup with roots in San Diego, said Monday that it’s landed $55 million in seed capital to develop technologies for delivering next-generation gene and cell therapies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback